The current status of erythropoietin.
D000740:Anemia / Q000188:drug therapy; D000741:Anemia, Aplastic / Q000097:blood / Q000188:drug therapy; D000818:Animals; D001803:Blood Transfusion; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002454:Cell Differentiation / Q000187:drug effects; D002908:Chronic Disease; D004920:Erythropoiesis; D004921:Erythropoietin / Q000032:analysis / Q000037:antagonists & inhibitors / Q000097:blood / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007106:Immune Sera; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000188:drug therapy; D008055:Lipids / Q000032:analysis; D015122:Mercaptopurine / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy / Q000378:metabolism
D007106:Immune Sera; D008055:Lipids; D004921:Erythropoietin; D015122:Mercaptopurine